One of the schistosomicides, it has been replaced largely by hycanthone and more recently praziquantel. (From Martindale The Extrapharmacopoeia, 30th ed., p46). It is currently being tested as a radiation sensitizer.
Intended for use as a radiation sensitizer in the treatment of brain cancer.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.